Correlation of toxicities and efficacies of pemetrexed with clinical factors and single-nucleotide polymorphisms: a prospective observational study.

MLA

Takeda, Yuichiro, et al. “Correlation of Toxicities and Efficacies of Pemetrexed with Clinical Factors and Single-Nucleotide Polymorphisms: A Prospective Observational Study.” BMC Cancer, vol. 23, no. 1, Aug. 2023, p. 800. EBSCOhost, https://doi.org/10.1186/s12885-023-11257-8.

APA

Takeda, Y., Naka, G., Katsuya, Y., Kobayashi, K., Suzuki, M., Hashimoto, M., Hirano, S., & Uemura, Y. (2023). Correlation of toxicities and efficacies of pemetrexed with clinical factors and single-nucleotide polymorphisms: a prospective observational study. BMC Cancer, 23(1), 800. https://doi.org/10.1186/s12885-023-11257-8

Chicago

Takeda, Yuichiro, Go Naka, Yuki Katsuya, Konomi Kobayashi, Manabu Suzuki, Masao Hashimoto, Satoshi Hirano, and Yukari Uemura. 2023. “Correlation of Toxicities and Efficacies of Pemetrexed with Clinical Factors and Single-Nucleotide Polymorphisms: A Prospective Observational Study.” BMC Cancer 23 (1): 800. doi:10.1186/s12885-023-11257-8.